Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

First Interim Dividend

20 Dec 2021 15:09

RNS Number : 2455W
Aberdeen Latin American Inc Fd Ltd
20 December 2021
 

Aberdeen Latin American Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

20 December 2021

 

First Interim Dividend

In accordance with the Company's stated aim to pay a minimum dividend of 3.5p pence per share for the year, the Board of Aberdeen Latin American Income Fund Limited (the "Company") has today declared a first interim dividend of 0.875p per Ordinary share (2021: 0.875p) in respect of the year ending 31 August 2022 payable on 28 January 2022 to Ordinary shareholders on the register at close of business on 7 January 2022 (ex-dividend date 6 January 2022).

The Board is aware of the importance of income to the Company's shareholders and has maintained the dividend at the same rate as last year.

The Board continually assesses the impact on earnings resulting from the ongoing Covid-19 pandemic. Latin American governments continue to try to manage the effect of Covid-19 on their economies and our investee companies are seeking to manage volatile trading conditions as inflationary pressures mount. The Directors have previously noted the revenue reserve that has been built up and one of the benefits of the investment company structure is the ability to use accumulated reserves to maintain distributions to shareholders where there is a shortfall in earnings.

The Board's intention is that interim dividends will continue to be paid quarterly, subject to cash levels and reserves being sufficient to allow the Company to do so. The Directors place great emphasis on exercising prudence, particularly in these uncertain times, and on ensuring that the robustness of the Company's balance sheet is maintained. The Board continues to monitor closely the ongoing impact of Covid-19 and its variants and the success of the vaccine roll-out, together with its ramifications for the region, valuations and recurring earnings, while taking into account the income requirements of its shareholders, and will keep future dividend policy under review. 

abrdn Capital International Limited

Manager and Company Secretary

 

End

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBUBDDIGDDGBG
Date   Source Headline
9th Nov 202212:26 pmRNSNet Asset Value(s)
8th Nov 202212:35 pmRNSNet Asset Value(s)
7th Nov 20222:56 pmRNSGearing disclosure
7th Nov 202212:28 pmRNSNet Asset Value(s)
4th Nov 20226:05 pmRNSMonth End Net Asset Value(s)
4th Nov 202212:51 pmRNSNet Asset Value(s)
3rd Nov 202212:42 pmRNSNet Asset Value(s)
2nd Nov 202212:38 pmRNSNet Asset Value(s)
31st Oct 20221:48 pmRNSGearing disclosure
31st Oct 202212:21 pmRNSNet Asset Value(s)
28th Oct 20221:13 pmRNSNet Asset Value(s)
27th Oct 202212:10 pmRNSNet Asset Value(s)
26th Oct 202212:40 pmRNSNet Asset Value(s)
25th Oct 202212:11 pmRNSNet Asset Value(s)
24th Oct 20224:05 pmRNSGearing Disclosure
24th Oct 20221:11 pmRNSNet Asset Value(s)
21st Oct 202212:53 pmRNSNet Asset Value(s)
20th Oct 20223:25 pmRNSNet Asset Value(s)
19th Oct 20225:56 pmRNSNet Asset Value(s)
18th Oct 20221:00 pmRNSNet Asset Value(s)
17th Oct 20223:45 pmRNSPortfolio Disclosure
17th Oct 20223:10 pmRNSGearing Disclosure
17th Oct 202212:32 pmRNSNet Asset Value(s)
17th Oct 202212:03 pmRNSGearing Disclosure
14th Oct 20221:28 pmRNSNet Asset Value(s)
13th Oct 20225:21 pmRNSHolding(s) in Company
13th Oct 202212:29 pmRNSNet Asset Value(s)
12th Oct 20221:30 pmRNSNet Asset Value(s)
11th Oct 202212:53 pmRNSNet Asset Value(s)
10th Oct 20224:35 pmRNSGearing Disclosure
10th Oct 20221:41 pmRNSNet Asset Value(s)
7th Oct 20221:00 pmRNSNet Asset Value(s)
7th Oct 202210:43 amRNSMonth End Net Asset Value(s)
6th Oct 202212:55 pmRNSNet Asset Value(s)
5th Oct 202212:53 pmRNSNet Asset Value(s)
4th Oct 202212:19 pmRNSNet Asset Value(s)
4th Oct 202211:01 amRNSGearing disclosure
3rd Oct 202211:07 amRNSCompliance with Market Abuse Regulation
30th Sep 20226:02 pmRNSHolding(s) in Company
30th Sep 20223:50 pmRNSHolding(s) in Company
30th Sep 202212:48 pmRNSNet Asset Value(s)
29th Sep 202212:33 pmRNSNet Asset Value(s)
28th Sep 202212:39 pmRNSNet Asset Value(s)
27th Sep 202212:56 pmRNSNet Asset Value(s)
26th Sep 20222:36 pmRNSGearing disclosure
26th Sep 20221:03 pmRNSNet Asset Value(s)
23rd Sep 202212:37 pmRNSNet Asset Value(s)
22nd Sep 202212:15 pmRNSNet Asset Value(s)
21st Sep 20221:52 pmRNSNet Asset Value(s)
20th Sep 20224:54 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.